Outcomes Following Restor IOL Lens Implant
Conditions
Keywords
Higher Order Abberations
Brief summary
To evaluate the clinical outcomes of AcrySof® ReSTOR® IOL for the Faculty Practice at UTSW Medical Center at Dallas
Detailed description
The AcrySof® ReSTOR® intraocular lens (IOL) is the latest advance in vision surgery. This IOL has been uniquely designed to improve vision throughout the entire visual spectrum, up close, far away and everything in-between. Thus, giving cataract patients their best chance ever to function free of glasses. The pre-operative and post-operative data from ReSTOR® IOL implant cataract surgeries will be analyzed to determine whether the desired outcome was achieved, i.e. excellent vision with no correction. Variables to be studied include patient age, gender, number of ReSTOR® IOL implants, ocular comorbidities, preoperative and postoperative corrected and uncorrected visual acuities, keratometry readings, and corneal topography readings. A patient survey will also be sent to patients having undergone the surgery to measure their level of satisfaction. Project Goals: The ultimate outcome of this project is to learn more insight on the following: 1. Visual acuity with and without correction of distance and near at 3-6 months 2. Percent of patients requiring keratorefractive surgery 3. Ocular comorbidity subgroup analysis 4. Monocular implantation subanalysis (prior to LASIK) 5. Comparison of post-op spherical equivalent to target refraction 6. Posterior capsule opacity that may be treated with laser procedure known as a YAG laser capsulotomy? 7. Subjective patient satisfaction 8. Validated questionnaire assessing visual function and quality of life
Interventions
DEVICERestor IOL
Sponsors
University of Texas Southwestern Medical Center
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
All patients of any race and sex between the ages of 18-90 years of age who have undergone ReSTOR® IOL cataract surgery will be recruited in this retrospective project.
Exclusion criteria
Patients who underwent conventional IOL cataract extraction surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Visual acuity with and without correction of distance and near at 3-6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Ocular comorbidity subgroup analysis | — |
| Monocular implantation subanalysis (prior to LASIK) | — |
| Comparison of post-op spherical equivalent to target refraction | — |
| Percent of patients requiring keratorefractive surgery | — |
| Subjective patient satisfaction | — |
| Validated questionnaire assessing visual function and quality of life | — |
| Posterior capsule opacity that may be treated with laser procedure known as a YAG laser capsulotomy? | — |
Countries
United States
Outcome results
None listed